Publicaciones en las que colabora con JOSE VICENTE CASTELL RIPOLL (47)

2016

  1. Silencing of hepatic fate-conversion factors induce tumorigenesis in reprogrammed hepatic progenitor-like cells

    Stem Cell Research and Therapy, Vol. 7, Núm. 1

2013

  1. Gata4 blocks somatic cell reprogramming by directly repressing Nanog

    Stem Cells, Vol. 31, Núm. 1, pp. 71-82

2012

  1. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs

    Toxicological Sciences, Vol. 127, Núm. 1, pp. 187-198

2009

  1. Cytometric analysis for drug-induced steatosis in HepG2 cells

    Chemico-Biological Interactions, Vol. 181, Núm. 3, pp. 417-423

  2. Fluorescent benzofurazan-cholic acid conjugates for in vitro assessment of bile acid uptake and its modulation by drugs

    ChemMedChem, Vol. 4, Núm. 3, pp. 466-472

  3. Synthesis of new, UV-photoactive dansyl derivatives for flow cytometric studies on bile acid uptake

    Organic and Biomolecular Chemistry, Vol. 7, Núm. 23, pp. 4973-4980

2008

  1. Identification of apoptotic drugs: Multiparametric evaluation in cultured hepatocytes

    Current Medicinal Chemistry, Vol. 15, Núm. 20, pp. 2071-2085

  2. Photophysical characterization and flow cytometry applications of cholylamidofluorescein, a fluorescent bile acid scaffold

    Photochemical and Photobiological Sciences, Vol. 7, Núm. 7, pp. 860-866

2007

  1. A human hepatocellular in vitro model to investigate steatosis

    Chemico-Biological Interactions, Vol. 165, Núm. 2, pp. 106-116

2005

  1. Multiparametric characterization by flow cytometry of flow-sorted subpopulations of a human hepatoma cell line useful for drug research

    Cytometry Part A, Vol. 63, Núm. 1, pp. 48-58

2004

  1. Drug metabolism by cultured human hepatocytes: How far are we from the in vivo reality?

    ATLA Alternatives to Laboratory Animals, Vol. 32, Núm. 2, pp. 101-110

  2. The immunosuppressant drug FK506 prevents Fas-induced apoptosis in human hepatocytes

    Biochemical Pharmacology, Vol. 68, Núm. 12, pp. 2427-2433

2003

  1. Diclofenac induces apoptosis in hepatocytes

    Toxicology in Vitro

  2. Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS

    Biochemical Pharmacology, Vol. 66, Núm. 11, pp. 2155-2167

  3. Human hepatic cell cultures: In vitro and in vivo drug metabolism

    ATLA Alternatives to Laboratory Animals

  4. Induction of hepatic heme oxygenase-1 by diclofenac in rodents: Role of oxidative stress and cytochrome P-450 activity

    Journal of Hepatology, Vol. 38, Núm. 6, pp. 776-783

2001

  1. Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

    Journal of Hepatology, Vol. 34, Núm. 1, pp. 19-25

  2. Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2

    European Journal of Biochemistry, Vol. 268, Núm. 5, pp. 1448-1459

  3. Role of endogenous nitric oxide in liver-specific functions and survival of cultured rat hepatocytes

    Xenobiotica, Vol. 31, Núm. 5, pp. 249-264

2000

  1. Expression of liver specific-genes in hepatocytes cultured in collagen gel matrix.

    Progress in molecular and subcellular biology, Vol. 25, pp. 89-104